ASX:DNK Danakali (DNK) Stock Price, News & Analysis → His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad) Free DNK Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield3.58%Price TargetN/A Stock AnalysisStock AnalysisDividendInsider TradesStock AnalysisDividendInsider Trades Get Danakali alerts: Email Address Ad Investing DailyHis win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. About DanakaliDanakali Limited, together with its subsidiaries, engages in the exploration of minerals in Eritrea, East Africa. The company focuses on the development of the Colluli potash project located in the Danakil Depression region of Eritrea. The company was formerly known as South Boulder Mines Ltd. and changed its name to Danakali Limited in June 2015. Danakali Limited was incorporated in 2001 and is based in North Perth, Australia.Read More Ad Investing DailyHis win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. DNK Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive DNK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Danakali and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorBasic Materials Industry Agricultural Inputs Sub-IndustryN/A Current SymbolASX:DNK CUSIPN/A CIKN/A Webwww.danakali.com.au Phone61-8-6266-8368FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,040,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-2.35% Return on Assets-2.12% Debt Debt-to-Equity RatioN/A Current Ratio838.35 Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.52 per share Price / BookN/AMiscellaneous Outstanding Shares368,330,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.74 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Seamus Ian Cornelius B.Juris (Age 58)L.L.B., L.L.M., LLB, LLM, Executive Chairman Comp: $248.06kMr. Gregory Ian MacPhersonChief Financial OfficerDr. Roderick Joseph McEachern (Age 66)Chief Operating Officer Comp: $469.92kMs. Melissa Kate Chapman A.C.I.S.AGIA, B.Com., C.P.A., Joint Company SecretaryMs. Catherine Grant-Edwards B.Com.C.A., Joint-Company SecretaryKey CompetitorsAbundant Produce Limited (ABT.AX)ASX:ABTBelgravia Capital InternationalCNSX:BLGVDanakaliOTCMKTS:SBMSFFertozASX:FTZHighfield ResourcesASX:HFRView All CompetitorsInsidersSeamus CorneliusSold 4,000,000 sharesTotal: $300,000.00 ($0.08/share)Seamus CorneliusSold 5,135,992 sharesTotal: $2.11 M ($0.41/share)Seamus CorneliusSold 43,000 sharesTotal: $17,630.00 ($0.41/share)View All Insider Transactions DNK Stock Analysis - Frequently Asked Questions How often does Danakali pay dividends? What is the dividend yield for Danakali? Danakali announced a Interim dividend on Thursday, December 7th. Shareholders of record on Saturday, January 7th will be given a dividend of 0.147 per share on Saturday, January 7th. This represents a yield of 35.91%. The ex-dividend date of this dividend is Thursday, December 28th. Read our dividend analysis for DNK. What other stocks do shareholders of Danakali own? Based on aggregate information from My MarketBeat watchlists, some companies that other Danakali investors own include Knowles (KN), Aurinia Pharmaceuticals (AUPH), Athenex (ATNX), Ascendis Pharma A/S (ASND), Ardelyx (ARDX), Arcturus Therapeutics (ARCT), Aptose Biosciences (APTO), Fresh2 Group (ANPC), Allstate (ALL) and Agility Health (AHI). This page (ASX:DNK) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Danakali Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.